Dumont & Blake Investment Advisors LLC Autolus Therapeutics PLC Transaction History
Dumont & Blake Investment Advisors LLC
- $358 Million
- Q2 2025
A detailed history of Dumont & Blake Investment Advisors LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Dumont & Blake Investment Advisors LLC holds 15,000 shares of AUTL stock, worth $22,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$22,500
Previous $24,000
41.67%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
165MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$40.7 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$30.7 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$25.4 Million5.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$25.3 Million1.36% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$25 Million98.24% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $136M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...